Skip to content
Screener

Editas Medicine EDIT Q2 2026 earnings

Reported August 5, 2026 · After market close

Revenue$11.9MBeat by $9.0M
EPS-$0.15Beat by $0.12
Revenue estimate$2.8M
EPS estimate-$0.27

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$4.5M
EPS estimate-$0.21

FAQ

When did Editas Medicine report Q2 2026 earnings?
Editas Medicine (EDIT) reported Q2 2026 earnings on August 5, 2026 after market close.
What were Editas Medicine's Q2 2026 revenue and EPS?
Editas Medicine reported revenue of $11.9M and eps of $-0.15 for Q2 2026.
Did Editas Medicine beat estimates in Q2 2026?
Revenue beat the consensus estimate of $2.8M by $9.0M. EPS beat the consensus estimate of $-0.27 by $0.12.
How did Editas Medicine's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 232.3% from $3.6M a year earlier and eps grew 76.2% from $-0.63.
Where can I find Editas Medicine's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001650664-26-000082) and the 10-Q periodic report (0001650664-26-000083) directly on SEC EDGAR. The filing index links above go to sec.gov.